In the latest trading session, 0.7 million Clover Health Investments Corp (NASDAQ:CLOV) shares changed hands as the company’s beta touched 2.00. With the company’s most recent per share price at $4.11 changed hands at -$0.07 or -1.56% at last look, the market valuation stands at $2.06B. CLOV’s current price is a discount, trading about -18.49% off its 52-week high of $4.87. The share price had its 52-week low at $0.61, which suggests the last value was 85.16% up since then.
Analysts gave the Clover Health Investments Corp (CLOV) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended CLOV as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Instantly CLOV was in red as seen in intraday trades today. With action -6.69%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 30.63%, with the 5-day performance at -6.69% in the red. However, in the 30-day time frame, Clover Health Investments Corp (NASDAQ:CLOV) is -14.63% down.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 31.5% from its recent market value. According to analyst projections, CLOV’s forecast low is 6 with 6 as the target high. To hit the forecast high, the stock’s price needs a -45.99% plunge from its current level, while the stock would need to soar -45.99% for it to hit the projected low.
Clover Health Investments Corp (CLOV) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -585.84%. The 2025 estimates are for Clover Health Investments Corp earnings to increase by 73.22%, but the outlook for the next 5-year period is at 47.91% per year.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
RENAISSANCE TECHNOLOGIES LLC holds the second largest percentage of outstanding shares, with 2.3123% or 11.27 million shares worth $13.86 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 10.94 shares estimated at $44.74 million under it, the former controlled 2.65% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.47% of the shares, roughly 6.07 shares worth around $24.84 million.
